GOSSAMER BIO, INC. Increase (Decrease) in Prepaid Expense and Other Assets
GOSSAMER BIO, INC. (GOSS) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$8.89 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$6.47M, a 245.73% decline year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$2.42M, a 360.91% decline year-over-year.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $3.96M.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$879.00K.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $8.45M.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2024 was -$62.00K, a 101.59% decline from fiscal 2023.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was $3.89M.
- GOSSAMER BIO, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$296.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$8.89M 10-Q · filed 2026-08-13 | -$4.93M derived: sum of 3 quarters · filed 2026-08-13 | -$5.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$2.42M 10-Q · filed 2026-05-15 | $1.55M derived: sum of 2 quarters · filed 2026-05-15 | $668.00K derived: sum of 3 quarters · filed 2026-05-15 | $5.11M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $3.08M derived: sum of 2 quarters · filed 2026-03-17 | $7.53M derived: sum of 3 quarters · filed 2026-08-13 | $8.45M 10-K · filed 2026-03-17 |
| 2025-09-30 | -$879.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.56M derived: sum of 2 quarters · filed 2026-08-13 | $4.49M 10-Q · filed 2025-11-05 | $3.88M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $4.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.37M 10-Q · filed 2026-08-13 | $4.75M derived: sum of 3 quarters · filed 2026-08-13 | $2.62M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $926.00K 10-Q · filed 2026-05-15 | $312.00K derived: sum of 2 quarters · filed 2026-05-15 | -$1.83M derived: sum of 3 quarters · filed 2026-05-15 | $83.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$614.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$2.75M derived: sum of 2 quarters · filed 2026-03-17 | -$843.00K derived: sum of 3 quarters · filed 2026-03-17 | -$62.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | -$2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$229.00K derived: sum of 2 quarters · filed 2025-11-05 | $552.00K 10-Q · filed 2025-11-05 | -$1.96M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | $1.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $2.69M 10-Q · filed 2025-08-05 | $184.00K derived: sum of 3 quarters · filed 2026-03-17 | $1.54M derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | $781.00K 10-Q · filed 2025-05-15 | -$1.73M derived: sum of 2 quarters · filed 2026-03-17 | -$375.00K derived: sum of 3 quarters · filed 2026-03-17 | $2.32M derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | -$1.16M derived: sum of 2 quarters · filed 2026-03-17 | $1.54M derived: sum of 3 quarters · filed 2026-03-17 | $3.89M 10-K · filed 2026-03-17 |
| 2023-09-30 | $1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.04M derived: sum of 2 quarters · filed 2024-11-07 | $6.40M 10-Q · filed 2024-11-07 | $4.95M derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | $2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $5.05M 10-Q · filed 2024-08-12 | $3.60M derived: sum of 3 quarters · filed 2025-03-13 | $729.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $2.35M 10-Q · filed 2024-05-07 | $908.00K derived: sum of 2 quarters · filed 2025-03-13 | -$1.96M derived: sum of 3 quarters · filed 2025-03-13 | -$530.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | -$4.32M derived: sum of 2 quarters · filed 2025-03-13 | -$2.88M derived: sum of 3 quarters · filed 2025-03-13 | -$296.00K 10-K · filed 2025-03-13 |
| 2022-09-30 | -$2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$1.44M derived: sum of 2 quarters · filed 2023-11-09 | $1.15M 10-Q · filed 2023-11-09 | -$259.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $4.02M 10-Q · filed 2023-08-08 | $2.61M derived: sum of 3 quarters · filed 2024-03-05 | $19.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $2.59M 10-Q · filed 2023-05-09 | $1.18M derived: sum of 2 quarters · filed 2024-03-05 | -$1.42M derived: sum of 3 quarters · filed 2024-03-05 | -$2.90M derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$4.00M derived: sum of 2 quarters · filed 2024-03-05 | -$5.49M derived: sum of 3 quarters · filed 2024-03-05 | -$2.63M 10-K · filed 2024-03-05 |
| 2021-09-30 | -$2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$4.08M derived: sum of 2 quarters · filed 2022-11-03 | -$1.22M 10-Q · filed 2022-11-03 | -$2.92M derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.37M 10-Q · filed 2022-08-09 | -$326.00K derived: sum of 3 quarters · filed 2023-03-17 | $2.47M derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-03-31 | $2.85M 10-Q · filed 2022-05-10 | $1.16M derived: sum of 2 quarters · filed 2023-03-17 | $3.95M derived: sum of 3 quarters · filed 2023-03-17 | $2.71M derived: sum of 4 quarters · filed 2023-03-17 |
| 2020-12-31 | -$1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $1.09M derived: sum of 2 quarters · filed 2023-03-17 | -$144.00K derived: sum of 3 quarters · filed 2023-03-17 | $1.64M 10-K · filed 2023-03-17 |
| 2020-09-30 | $2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.55M derived: sum of 2 quarters · filed 2021-11-08 | $3.34M 10-Q · filed 2021-11-08 | $4.93M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $548.00K 10-Q · filed 2021-08-09 | $2.13M derived: sum of 3 quarters · filed 2022-03-03 | $698.00K derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $1.78M 10-Q · filed 2021-05-06 | $3.37M derived: sum of 2 quarters · filed 2022-03-03 | $1.94M derived: sum of 3 quarters · filed 2022-03-03 | $2.71M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $150.00K derived: sum of 2 quarters · filed 2022-03-03 | $921.00K derived: sum of 3 quarters · filed 2022-03-03 | $4.39M 10-K · filed 2022-03-03 |
| 2019-09-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$665.00K derived: sum of 2 quarters · filed 2020-11-10 | $2.81M 10-Q · filed 2020-11-10 | $4.19M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $771.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $4.24M 10-Q · filed 2020-08-11 | $5.63M derived: sum of 3 quarters · filed 2021-02-26 | $6.78M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $3.47M 10-Q · filed 2020-05-12 | $4.86M derived: sum of 2 quarters · filed 2021-02-26 | $6.01M derived: sum of 3 quarters · filed 2021-02-26 | $6.21M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.54M derived: sum of 2 quarters · filed 2021-02-26 | $2.73M derived: sum of 3 quarters · filed 2021-02-26 | $2.83M 10-K · filed 2021-02-26 |
| 2018-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $1.35M derived: sum of 2 quarters · filed 2019-11-12 | $1.44M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $197.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $291.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $94.00K 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | $130.00K 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |